Invokana Kidney Damage

Ohio Invokana Kidney Damage Lawyers

There is growing concern that a popular medication prescribed for Type II diabetes may cause ketoacidosis and kidney damages. If you or a loved one has suffered injury as a result of the use of Invokana, our legal team may be able to help.

On December 4, 2015, the U.S. Food and Drug Administration (“FDA”) issued a safety announcement concerning a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (“SGLT2”) inhibitors. The announcement warned of the risks of too much acid in the blood and of serious urinary tract infections, both of which can result in serious injuries and hospitalization.

Invokana (canagliflozin) is a SGLT2 class drug that is designed to control blood sugar levels in people diagnosed with type 2 diabetes. It works by helping the kidneys removed excess sugar from the body through urination.

What is the problem with Invokana?

According to the FDA, dozens of people have been hospitalized for ketoacidosis after ingesting SGLT2 class drugs. Ketoacidosis is serious condition in which the body produces high levels of blood acids called ketones. Symptoms of ketoacidosis include abdominal pain, breathing difficulties, nausea, vomiting, and tiredness.